Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -8.83 | -10.26 | 0.23 | 0.59 |
Depreciation/ Depletion | 4.50 | 2.67 | 1.32 | 1.25 |
Non- Cash Items | 5.71 | 5.89 | 2.35 | 2.12 |
Changesin Working Capital | 1.31 | 1.08 | 1.33 | 2.91 |
Cashfrom Operating Activities | 2.68 | -0.63 | 5.22 | 6.87 |
Capital Expenditures | -3.40 | -28.69 | -17.18 | -22.19 |
Other Investing Cash Flow Items Total | 0.09 | 22.78 | - | 0.00 |
Cashfrom Investing Activities | -3.31 | -5.91 | -17.18 | -22.19 |
Financing Cash Flow Items | -5.75 | -5.89 | -2.35 | -2.14 |
Issuance( Retirement)of Stock Net | 2.65 | 0.00 | 2.98 | 1.32 |
Issuance( Retirement)of Debt Net | 3.79 | 12.29 | 8.90 | 18.60 |
Cashfrom Financing Activities | 0.69 | 6.41 | 9.53 | 17.78 |
Net Changein Cash | 0.06 | -0.13 | -2.43 | 2.46 |
Cash Interest Paid | 5.75 | 5.89 | 2.35 | 2.14 |
Vanta Bioscience Dividend Vanta Bioscience Bonus Vanta Bioscience News Vanta Bioscience AGM Vanta Bioscience Rights Vanta Bioscience Splits Vanta Bioscience Board Meetings Vanta Bioscience Key Metrics Vanta Bioscience Shareholdings Vanta Bioscience Profit Loss Vanta Bioscience Balance Sheet Vanta Bioscience Q1 Results Vanta Bioscience Q2 Results Vanta Bioscience Q3 Results Vanta Bioscience Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks